What is the recommended tapering schedule for discontinuing quetiapine?

How to Stop Quetiapine

Taper quetiapine gradually rather than stopping abruptly, though the FDA label notes that abrupt discontinuation may be acceptable for some patients with schizophrenia while more gradual discontinuation may be appropriate for others 1.

Tapering Approach

General Principles

The FDA label does not provide a specific tapering schedule for quetiapine discontinuation 1. However, based on the pharmacological principles that apply to antipsychotic discontinuation and the drug's dosing characteristics, a structured approach is warranted:

For patients on quetiapine for dementia-related agitation/psychosis:

• If no clinically significant response after 4 weeks at an adequate dose, taper and withdraw the medication 2
• Before tapering, discuss with the patient (if feasible) and surrogate decision makers, reviewing initial goals, observed benefits, side effects, and risks of continued exposure 2
• If clinically significant side effects occur, review risk/benefit and determine if tapering and discontinuing is indicated 2

Practical Tapering Strategy

While no specific quetiapine tapering schedule exists in guidelines, extrapolating from the FDA's reinitiation guidance and general antipsychotic principles:

Standard approach:

• Reduce dose by 25-50% every 1-2 weeks
• Monitor closely for withdrawal symptoms and symptom recurrence
• Slower tapers (over months) may be needed for patients on long-term therapy or those with prior difficulty discontinuing

Example taper from 400 mg/day:

• Week 1-2: 300 mg/day
• Week 3-4: 200 mg/day
• Week 5-6: 100 mg/day
• Week 7-8: 50 mg/day
• Week 9: Stop

For higher-risk patients (long duration of use, high doses, prior withdrawal difficulties):

• Consider smaller reductions (10-25% of current dose)
• Extend intervals between reductions to 2-4 weeks
• May require tapering over several months

Key Considerations

When Abrupt Discontinuation May Be Acceptable

The FDA label indicates immediate discontinuation of previous antipsychotic treatment may be acceptable for some patients with schizophrenia, though gradual discontinuation is more appropriate for others 1. The period of overlapping antipsychotic administration should be minimized when switching 1.

Reinitiation After Discontinuation

• If off quetiapine for more than one week: follow the initial dosing schedule (starting at 25-50 mg and titrating up) 1
• If off quetiapine for less than one week: gradual dose escalation may not be required and maintenance dose may be reinitiated 1

Monitoring During Tapering

• Assess for withdrawal symptoms every 1-2 weeks
• Differentiate withdrawal symptoms from symptom recurrence
• Be prepared to slow the taper, pause, or reverse if significant symptoms emerge
• For dementia patients, use quantitative measures to assess response 2

Common Pitfalls

• Tapering too quickly: This increases risk of withdrawal symptoms and symptom recurrence
• Not distinguishing withdrawal from relapse: Withdrawal symptoms typically emerge within days of dose reduction, while relapse develops more gradually
• Failing to involve patients/caregivers: Shared decision-making is essential, particularly for dementia patients where surrogate decision makers should be engaged 2
• Not adjusting taper based on individual response: Some patients require much slower tapers than others